OneStep, an all-in-one digital care platform that captures real-life mobility data from any smartphone, has announced a partnership with the Mount Sinai Health System, one of the largest academic medical systems in the US. This collaboration, which began two years ago when Mount Sinai recognized the transformative potential of OneStep's advanced gait analysis technology, has now progressed to a more comprehensive study of the efficacy of remote physical therapy (PT) programs.
The initiative represents a critical moment in the ongoing effort to provide advanced, efficient, and accessible PT solutions to patients worldwide. Its aim is to explore whether remote PT treatments can be equally, if not more, effective than traditional in-person care.
The collaboration will result in a joint research report that provides key insights on the effectiveness of remote PT, explores its financial viability, and validates key performance tests. A key aim of the final published research is to test the potential for remote PT patients to regain mobility or even improve at a faster rate than those receiving in-person care.
The project will also consider opportunities for reimbursement through Remote Therapeutic Monitoring (RTM) codes. This could have a significant impact on the widespread adoption of remote PT.
Through the partnership, Mount Sinai and OneStep will assess the validity of measurements for key physical performance tests when conducted remotely, including the Sit-To-Stand (STS) test, Timed Up and Go (TUG) test, and the 6 Minute Walk Test (6MWT).
In addition to the partnership with the Mount Sinai Health System, OneStep's collaboration includes New York University, the University of Haifa, Tel Aviv University, and the University of Utah Health. This research builds upon OneStep’s previous peer-reviewed validation and clinical studies that demonstrate its validity and reliability as the gold-standard gait analysis system.
By establishing remote PT as an essential part of healthcare services, this research will extend mobility benefits to those who previously have not been able to access PT, particularly individuals who face geographical, logistic, or time challenges.
“Through this research partnership, OneStep’s technology will have a significant impact on Mt. Sinai patients’ quality of life, which can hopefully be extended to many other patients around the world,” said Yuval Naveh, Chief Scientific Officer at OneStep. “We are committed to harnessing data-driven insights and driving better patient outcomes for all.”
About OneStep
OneStep uses smartphone motion sensors to continuously analyze movement in real-life conditions, providing clinically-validated gait and motion analysis data within seconds without any wearables. Our FDA-listed digital health platform equips clinicians with a full suite of remote PT protocols and tools that support remote therapeutic monitoring and enable clinicians to enhance decision making, intervene proactively, and help their patients reach their goals faster – by assessing health status sooner, more holistically, and from anywhere. We serve patients and physical therapists, as well as leading physical therapy providers, surgeon-owned clinics, orthotists and prosthetists, and medical device manufacturers. OneStep has demonstrated outstanding clinical outcomes and superior patient satisfaction while improving provider efficiencies, increasing revenue, and lowering costs. OneStep’s fall risk assessment was recently recognized as a World Changing Idea by Fast Company.
For more information, visit www.onestep.co/ or find OneStep on Linkedin, Facebook, Twitter, and Instagram.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
